Dermatology · Shrewsbury, MA
NPI
1780817189
Since 2009
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
555 Main St Ste 1
Shrewsbury, MA, 01545
Phone (508) 644-0505
Groups this clinician bills Medicare through
Medicare paid, 2024
$128K
3,745 services
Medicare patients, 2024
710
Average age 75
Drug cost, 2024
$1.0M
1,102 prescriptions
Company payments, 2025
$1,339
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Alissa T Lamoureux was code 17003 (destruction skin lesion), 1,490 times for 276 patients. In total Alissa T Lamoureux billed 3,745 services in 36 codes, and Medicare paid $128K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-05-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 1,490 | 276 | $4.37 | $6,509 |
| 99213 Office E&M - Established | Office | 883 | 567 | $53.11 | $47K |
| 17000 Destruction Skin Lesion | Office | 505 | 375 | $36.55 | $18K |
| 11102 Skin Biopsy | Office | 277 | 221 | $62.17 | $17K |
| 99203 Office E&M - New | Office | 135 | 135 | $60.27 | $8,137 |
| 99212 Office E&M - Established | Office | 101 | 84 | $34.41 | $3,476 |
| 11103 Skin Biopsy | Office | 83 | 55 | $35.03 | $2,908 |
| 17004 Destruction Skin Lesion | Office | 39 | 29 | $97.19 | $3,791 |
| 12032 Wound Repair - All Levels | Office | 32 | 29 | $190.40 | $6,093 |
| 17110 Destruction Skin Lesion | Office | 27 | 25 | $68.95 | $1,862 |
| 99202 Office E&M - New | Office | 22 | 22 | $33.87 | $745 |
| 11602 Skin Lesion Excision | Office | 18 | 16 | $86.11 | $1,550 |
| 17262 Destruction Skin Lesion | Office | 16 | 14 | $125.89 | $2,014 |
| 17272 Destruction Skin Lesion | Office | 13 | 11 | $111.36 | $1,448 |
| 99214 Office E&M - Established | Office | 13 | 11 | $87.46 | $1,137 |
By year: 2022 $152K for 3,772 services; 2023 $137K for 3,545 services; 2024 $128K for 3,745 services.
Medicare prescription drug claims, 2024
In 2024, the drug Alissa T Lamoureux prescribed most often to Medicare patients was Triamcinolone Acetonide, with 100 prescriptions and refills. In total Alissa T Lamoureux wrote 1,102 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Triamcinolone Acetonide Generic | 100 | 115 | 82 | $1,156 |
| Hydrocortisone Generic | 100 | 105 | 94 | $557 |
| Clobetasol Propionate Generic | 93 | 96 | 58 | $4,748 |
| Ammonium Lactate Generic | 84 | 84 | 31 | $2,009 |
| Fluorouracil Generic | 76 | 76 | 76 | $4,300 |
| Ketoconazole Generic | 59 | 63 | 29 | $782 |
| Metronidazole Generic | 46 | 48 | 21 | $3,426 |
| Mupirocin Generic | 38 | 40 | 31 | $272 |
| Desonide Generic | 28 | 28 | Under 11 | $6,620 |
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | 25 | 25 | 14 | $795 |
| Minoxidil Generic | 23 | 57 | Under 11 | $186 |
| Tretinoin Generic | 21 | 33 | 16 | $845 |
| Betamethasone Diprop Augmented Betamethasone Dipropionate | 20 | 20 | Under 11 | $2,041 |
| Pimecrolimus Generic | 19 | 19 | Under 11 | $4,179 |
| Doxycycline Hyclate Generic | 17 | 18 | 14 | $528 |
Brand drugs: 156 claims; generic drugs: 946 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Alissa T Lamoureux $1,339 ($1,339 in general payments such as food, travel and fees) from 17 companies. The largest payer was Janssen Biotech, Inc. with $297.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 10 | $297 |
| Revance Therapeutics, Inc. | 1 | $198 |
| UCB, Inc. UCB.BR | 3 | $123 |
| Abbvie Inc. ABBV | 3 | $94.79 |
| Merz North America, Inc. | 4 | $85.64 |
| Sanofi-Aventis U.S. LLC SNY | 1 | $79.99 |
| E.R. Squibb & Sons, L.L.C. BMY | 3 | $71.26 |
| Amgen Inc. AMGN | 2 | $66.45 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $61.9 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 2 | $56.17 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.